After the fasting, the uncomfortable cleanse and a drowsy ride home, it's a relief to have your colonoscopy screening behind ...

Colorectal cancer often begins as silent, benign polyps within the colon. These growths, initially small and undetectable, ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Last week's biggest large-cap laggards were Nike, Arm, and Lennar, sliding on weak China demand, analyst downgrades, earnings ...

As of Tuesday, December 23, Aclaris Therapeutics, Inc.’s ACRS share price has dipped by 7.82%, which has investors questioning if this is right time to buy.

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Hemorrhoids are one of the most common — and least discussed — medical problems in adults. They can cause itching, pain, ...

Savannah Guthrie will not be around for the new year on Today, but fans can rest assured that her absence will only be ...

We read with great interest the study by Van der Voort et al ,1 which compared rectal versus colonic submucosal cancer rates ...

In low-resource regions such as Nigeria, most people with colorectal cancer are diagnosed too late for curative treatment ...